Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

HLA class I expression in the human placenta.

Juch H, Blaschitz A, Dohr G, Hutter H.

Wien Med Wochenschr. 2012 May;162(9-10):196-200. doi: 10.1007/s10354-012-0070-7. Review.

PMID:
22717873
2.

HLA Class I protein expression in the human placenta.

Blaschitz A, Hutter H, Dohr G.

Early Pregnancy. 2001 Jan;5(1):67-9.

PMID:
11753519
3.

Immunological relationship between the mother and the fetus.

Szekeres-Bartho J.

Int Rev Immunol. 2002 Nov-Dec;21(6):471-95. Review.

PMID:
12650238
4.

Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia.

Goldman-Wohl DS, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, Yagel S.

Mol Hum Reprod. 2000 Jan;6(1):88-95.

6.

[Placentation in the human: a transplantation or tumor model?].

Marzusch K, Dietl J.

Z Geburtshilfe Neonatol. 1998 Mar-Apr;202(2):47-54. Review. German.

PMID:
9654713
7.

The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.

Agrawal S, Pandey MK.

J Hematother Stem Cell Res. 2003 Dec;12(6):749-56.

PMID:
14977483
8.

HLA-G and immune tolerance in pregnancy.

Hunt JS, Petroff MG, McIntire RH, Ober C.

FASEB J. 2005 May;19(7):681-93. Review.

9.

How Does the maternal immune system contribute to the development of pre-eclampsia?

Moffett A, Hiby SE.

Placenta. 2007 Apr;28 Suppl A:S51-6. Epub 2007 Feb 8.

PMID:
17292469
10.

Immune aspects of pathology of the placental bed contributing to pregnancy pathology.

Bulmer JN.

Baillieres Clin Obstet Gynaecol. 1992 Sep;6(3):461-88. Review.

PMID:
1332834
11.

[HLA-G: from feto-maternal tolerance to organ grafting].

Carosella ED.

Bull Mem Acad R Med Belg. 2009;164(3-4):87-99; discussion 99-101. French.

PMID:
20120086
12.

Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia.

Caniggia I, Winter J, Lye SJ, Post M.

Placenta. 2000 Mar-Apr;21 Suppl A:S25-30.

PMID:
10831118
13.

Expression of HLA class I molecules in human first trimester and term placenta trophoblast.

Hutter H, Hammer A, Blaschitz A, Hartmann M, Ebbesen P, Dohr G, Ziegler A, Uchanska-Ziegler B.

Cell Tissue Res. 1996 Dec;286(3):439-47. Erratum in: Cell Tissue Res 1997 Mar;287(3):625.

PMID:
8929346
14.

Maternal and fetal immune responses during pregnancy.

Sargent IL.

Exp Clin Immunogenet. 1993;10(2):85-102. Review.

PMID:
8251183
15.

[Immune tolerance of mother against fetus and placenta].

Donat H.

Allerg Immunol (Leipz). 1986;32(2):79-86. Review. German.

PMID:
2425616
16.

Why is the fetal allograft not rejected?

Davies CJ.

J Anim Sci. 2007 Mar;85(13 Suppl):E32-5. Epub 2006 Oct 13.

PMID:
17040952
17.

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.

Rouas-Freiss N, Gonçalves RM, Menier C, Dausset J, Carosella ED.

Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11520-5.

18.

Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A, Claas FH, Walker JJ, Redman CW, Morgan L, Tower C, Regan L, Moore GE, Carrington M, Moffett A.

J Clin Invest. 2010 Nov;120(11):4102-10. doi: 10.1172/JCI43998. Epub 2010 Oct 25. Erratum in: J Clin Invest. 2011 Jan 4;121(1):455. Redman, Christopher C [corrected to Redman, Christopher W].

19.

Major histocompatibility antigen expression on the bovine placenta: its relationship to abnormal pregnancies and retained placenta.

Davies CJ, Hill JR, Edwards JL, Schrick FN, Fisher PJ, Eldridge JA, Schlafer DH.

Anim Reprod Sci. 2004 Jul;82-83:267-80. Review.

PMID:
15271459
20.

Reproductive immunology: Immunity's pregnant pause.

Pearson H.

Nature. 2002 Nov 21;420(6913):265-6. No abstract available.

PMID:
12447413
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk